Tragacanth powder
Tragacanth allergenic extract is used in allergenic testing.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 29 studies.
Reviews & meta-analyses: 2 · 2023–2025
Showing all 29 studies, sorted by most relevant.
Zahra Nazemi, Maryam Sahraro, M. Janmohammadi, et al.
International journal of biological macromolecules, 2023
- Tragacanth
- Biocompatible Materials
- Excipients
Aamir Nawaz, Saad Alghamdi, M. Taj, et al.
Inorganic Chemistry Communications, 2024
Aidin Azadi, Fatemeth Rafieian, Masoud Sami, et al.
International journal of biological macromolecules, 2023
A. Rameshbabu, Didem Demir, P. Deol, et al.
Frontiers in Materials, 2024
Natural polymers have many uses, and Tragacanth gum is just one of them. Many people are interested in natural gums because of their many attractive characteristics, such as being ‘green’ bio-based renewable materials, being easily accessible, inexpensive, and structurally diverse. One class of naturally occurring polysaccharides is called gum because of its tendency to create a gel or a thick solution. Among the many plant-based raw materials, these polysaccharide gums are abundant. Hydrogels, which are three-dimensional polymeric webs that can imitate live tissues, have demonstrated remarkable potential as adjustable biomaterials in numerous regenerative techniques due to their high water or biological exudate absorption capacities. Natural polysaccharides, often known as gums, are present in many different types of trees and possess many desirable properties, such as being renewable, biocompatible, biodegradable, non-toxic, and amenable to chemical modification. Many people are curious about certain parts of the food, water, energy, biotech, environmental, and healthcare sectors as of now. Gum, a type of very important and unique food ingredient, has many vital uses in the food business. Cosmetics, coating, photosensitive resin, fertilizer, casting, pharmaceuticals, and tobacco are just a few of the non-food businesses that make use of their strong water-affinity and structural plasticity. There are a lot of benefits to hydrogels made from natural gums as opposed to those made from synthetic sources. Synthesis hydrogel polymers have been the center of interest among these non-food applications because of their extensive use in the pharmaceutical and medical fields. The Tragacanth gum hydrogels used for medication delivery and tissue engineering have been the focus of this study. We also paid close attention to drug delivery, physical-chemical properties, and the extraction of Tragacanth gum. Our research has a wide range of biomedical applications, including tissue engineering for bone, skin, fixation of bone, periodontal, and cartilage. Possible futures based on hydrogels made of Tragacanth gum were likewise our primary focus.
Abstract licence: CC BY
Habibeh Hashemian, M. Ghaedi, K. Dashtian, et al.
Sensors and Actuators B: Chemical, 2024
Tabassum, Akhil Babu, Hajeera Sheraz Ahmed, et al.
Journal of Applied Polymer Science, 2024
Shadan Irantash, A. Gholipour-Kanani, N. Najmoddin, et al.
Scientific Reports, 2024
- Alginates
- Anti-Bacterial Agents
- Fibroins
Hybrid structures made of natural-synthetic polymers have been interested due to high biological features combining promising physical-mechanical properties. In this research, a hybrid dressing consisting of a silk fibroin (SF)/polyvinyl alcohol (PVA) nanofibers and sodium alginate (SA)/gum tragacanth (GT) hydrogel incorporating cardamom extract as an antibacterial agent was prepared. Accordingly, SF was extracted from cocoons followed by electrospinning in blend form with PVA (SF/PVA ratio: 1:1) under the voltage of 18 kV and the distances of 15 cm. The SEM images confirmed the formation of uniform, bead free fibers with the average diameter of 199 ± 28 nm. FTIR and XRD results revealed the successful extraction of SF and preparation of mixed fibrous mats. Next, cardamom oil extract-loaded SA/GT hydrogel was prepared and the nanofibrous structure was placed on the surface of hydrogel. SEM analysis depicted the uniform morphology of hybrid structure with desirable matching between two layers. TGA analysis showed desired thermal stability. The swelling ratio was found to be 1251% after 24 h for the hybrid structure and the drug was released without any initial burst. MTT assay and cell attachment results showed favorable biocompatibility and cell proliferation on samples containing extract, and antibacterial activity values of 85.35% against S. aureus and 75% against E. coli were obtained as well. The results showed that the engineered hybrid nanofibrous-hydrogel film structure incorporating cardamom oil extract could be a promising candidate for wound healing applications and skin tissue engineering.
Abstract licence: CC BY
Afsaneh Ghani, E. Zare, Pooyan Makvandi, et al.
Carbohydrate Polymer Technologies and Applications, 2024
Bioactive films based on sodium carboxymethyl tragacanth gum (CMT) and polyvinyl alcohol (PVA) enriched with clove extract (CE) for potential wound healing applications were fabricated by the solution casting method. The fabricated films were characterized by FTIR, XRD, EDX, SEM, and TGA analyses. The XRD pattern of CMT/PVA/CE5% showed an amorphous structure with broad peaks, suggesting that the presence of CE led to a reduction in crystallinity and an increase in amorphousness in the polymer film. The fabricated films showed a high water absorption capacity and swelled up to 80% over 24 hours for the CMT/PVA/CE5% formulation crosslinked with 15% citric acid. Excellent biodegradability with 88% was observed in soil over 40 days for CMT/PVA/CE5%. The presence of CE in CMT/PVA improved the antioxidant activity by up to 92% within 30 minutes. Strong antibacterial effects of CMT/PVA/CE5% film were observed against Salmonella enterica and Staphylococcus aureus, with inhibition zone diameters of 20 mm and 18 mm, respectively. Across concentrations from 25-600 μg/mL, CMT/PVA/CE5% films displayed over 80% cell viability on cultured human dermal fibroblasts after 48 hours. The results indicated that CMT/PVA/CE5% bioactive film can be employed as effective, non-toxic wound dressings with infection prevention and healing promotion capabilities.
Abstract licence: CC BY-NC-ND
Roberta Teixeira Polez, Erfan Kimiaei, Zahra Madani, et al.
International journal of biological macromolecules, 2024
- Cellulose
- Tragacanth
- Hydrogels
This study investigates a novel all-polysaccharide hydrogel composed of tragacanth gum (TG) and cellulose nanocrystals (CNCs), eliminating the need for toxic crosslinkers. Designed for potential tissue engineering applications, these hydrogels were fabricated using 3D printing and freeze-drying techniques to create scaffolds with interconnected macropores, facilitating nutrient transport. SEM images revealed that the hydrogels contained macropores with a diameter of 100–115 μm. Notably, increasing the CNC content within the TG matrix (30–50 %) resulted in a decrease in porosity from 83 % to 76 %, attributed to enhanced polymer-nanocrystal interactions that produced denser networks. Despite the reduced porosity, the hydrogels demonstrated high swelling ratios (890–1090 %) due to the high water binding capacity of the hydrogel. Mechanical testing showed that higher CNC concentrations significantly improved compressive strength (27.7–49.5 kPa) and toughness (362–707 kJ/m 3 ), highlighting the enhanced mechanical properties of the hydrogels. Thermal analysis confirmed stability up to 400 °C and verified ionic crosslinking with CaCl₂. Additionally, hemolysis tests indicated minimal hemolytic activity, affirming the biocompatibility of the TG/CNC hydrogels. These findings highlight the potential of these hydrogels as advanced materials for 3D-printed scaffolds and injectable hydrogels, offering customizable porosity, superior mechanical strength, thermal stability, and biocompatibility. • Developed all-polysaccharide hydrogel using TG and CNCs, avoiding toxic crosslinkers. • 3D printed and freeze-dried hydrogels created porous scaffolds with interconnected pores. • CNCs reinforcement improves network density, rigidity, and control over porosity and swelling. • Hydrogels show low hemolytic activity, highlighting potential for tissue engineering applications. • Versatile application potential, including injectable hydrogels and 3D-printed scaffolds.
Abstract licence: CC BY
Mercedeh Babaluei, Yasamin Mojarab, F. Mottaghitalab, et al.
International journal of biological macromolecules, 2024
- Burns
- Fibroins
- Tragacanth
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Tragacanth
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Molecular structure
Linked open data from Wikidata (Q423901), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. Molecular structure images from Wikimedia Commons.